Sorafenib and thyrotoxicosis

J Endocrinol Invest. 2010 Jun;33(6):436. doi: 10.1007/BF03346617.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Benzenesulfonates / adverse effects*
  • Humans
  • Liver Neoplasms / drug therapy
  • Male
  • Middle Aged
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Prednisone / therapeutic use
  • Pyridines / adverse effects*
  • Sorafenib
  • Thyrotoxicosis / chemically induced*
  • Thyrotoxicosis / drug therapy

Substances

  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib
  • Prednisone